Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
A randomized, open-label, single-dosing, 2x2 crossover study to compare the safety and
pharmacokinetics of HUG116 tablet(Tenofovir Disoproxil) with Viread® tablet(Tenofovir
Disoproxil Fumarate) in healthy male volunteers